(19)

(11)

EP 4 816 558 A1

(12)

(43) Date of publication: 07.10.2026 Bulletin 2026/41 (21) Application number: 24898814.9 (22) Date of filing: 27.11.2024

(51) International Patent Classification (IPC):  C12Q 1/6883(2018.01) C12Q 1/68(2018.01) G01N 33/50(2006.01) A61P 25/28(2006.01) (52) Cooperative Patent Classification (CPC): C12Q 1/6883; A61P 25/28; G01N 33/6896; G01N 2800/52; G01N 2800/385; G01N 2800/28; C12Q 2600/158; C12Q 2600/106 (86) International application number: PCT/US2024/057864 (87) International publication number: WO 2025/117826 (05.06.2025 Gazette 2025/23)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA Designated Validation States: GE KH MA MD TN (30) Priority: 30.11.2023 US 202363604513 P 23.09.2024 US 202463697927 P (71) Applicant: Anavex Life Sciences Corp. New York, NY 10111 (US)	(72) Inventor: MISSLING, Christopher, U. New York, New York 10111 (US) (74) Representative: SONN Patentanwälte GmbH & Co KG  Riemergasse 14 1010 Wien 1010 Wien (AT)